Patrick Campbell

An analysis of 60,000-plus patients over 2 decades suggests consumption of olive oil could help reduce rate of CVD.

While the apparent cardiovascular benefits of olive oil have been proven in studies examining European populations, new research from a team of Harvard physicians is shedding light on impact in US patients.

A discussion on how COVID-19 has changed the role of cardiologists and the use of telehealth in clinical practice.

New research suggests the presence of a maternal hypertensive disorder predicts increased risk of childhood mental disorder, regardless of mental disorder status of the parents.

Discussion the debate around use of ACE inhibitors and ARBS as well as other common questions the ESC has been fielding during the ongoing outbreak.

The surgical resource document contains guidance on topics ranging from testing policies to ensuring the delivery of high-quality care.

The new document highlights the need for planning and resource allocation during the ongoing outbreak.

New research from a feasibility trial suggests new technology could help patients achieve BP control at a similar rate as regular visits.

An analysis from the Women's Health Initiative has uncovered a potential link between visual impairment and risk of incident dementia.

The Penn Medicine trial is currently enrolling and will evaluate effects across a multitude of outcomes.

In the largest analysis of its kind, a team of investigators from Italy are shedding new light on the impact of aspirin use and risk of cancers of the digestive tract.

Aspirin, the popular and well-established therapy for cardiovascular disease may have a new role in treating cancers of the digestive tract.

In an effort to settle the debate surrounding the use of ACE inhibitors (ACEI) and ARBs during the ongoing coronavirus disease 2019 (COVID-19) outbreak, investigators from Perelman School of Medicine at the University of Pennsylvania, recently launched a new clinical trial.  The REPLACE COVID trial plans to recruit 152 hospitalized patients already taking medications from the classes, with the goal of determining whether discontinuing use affects the severity of disease symptoms.

In an effort to settle the debate surrounding the use of ACE inhibitors (ACEI) and ARBs during the ongoing coronavirus disease 2019 (COVID-19) outbreak, investigators from Perelman School of Medicine at the University of Pennsylvania, recently launched a new clinical trial.  The REPLACE COVID trial plans to recruit 152 hospitalized patients already taking medications from the classes, with the goal of determining whether discontinuing use affects the severity of disease symptoms.

New research is shedding light on the long-term outcomes of percutaneous coronary intervention in patients with stable ischemic heart disease.

Bhatt leads discussion on a new AHA statement regarding one of the most advancing fields of cardiovascular care.

New research from the California Department of Public Health is shedding new light on the impact of wildfire smoke on out-of-hospital cardiac arrest.

Using combined data from the National Ocean Atmospheric Association’s (NOAA) Hazard Mapping System and the Cardiac Arrest Registry to Enhance Survival (CARES) from 14 California counties, investigators from the California’s Department of Public Health have uncovered a startling link between wildfires and a sharp rise in out-of-hospital cardiac arrests.  Heavy wildfire smoke increased risk of out-of-hospital cardiac arrests by as much as 70%, researchers report.

A new Emory University-led study is shedding more light on the impact mental stress can have on cardiovascular health.

A discussion about a recent scientific statement outlining the treatment of coronary artery disease in type 2 diabetics from the AHA with statement co-author Deepak Bhatt, MD.

Deepak Bhatt, MD, MPH, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital talks with HCPLive's Patrick Campbell about the American Heart Association's recommendations from the lipid management portion oftheir scientific statement discussing both coronary artery disease (CAD) and type 2 diabetes (T2D).

New research from Emory University is shedding light on a potential link between post-traumatic stress disorder (PTSD) and mental stress-induced myocardial ischemia in patients with stable coronary artery disease.  The study, led by Viola Vaccarino, MD, PhD, of the department of epidemiology at Emory University Rollins School of Public Health, found that patients with stable coronary artery disease who survived a recent myocardial infarction (MI) and had PTSD were at a greater risk of developing myocardial ischemia than those who did not have PTSD.

CytoSorbents Corporation announced the authorization, which could aid multiple patient populations infected with COVID-19.

A new study analyzing at-home blood pressure devices available for purchase online has found most are not validated—bringing their accuracy into question.

A new scientific statement from the AHA offers guidance to clinicians tasked with treating CAD in patients with type 2 diabetes.

A long-form discussion with a pair of professors and pediatricians from the University of Florida College of Medicine.

New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.

An interview with a pair of pediatricians and professors from the University of Florida College of Medicine discussing the use of telehealth in COVID-19.

New data in JAMA Ophthalmology is examining the impact of ocular injuries from the NEISS database.

Results of a 26-year study examine the impact of a dozen different lifestyle interventions in a cohort from the Nurses Health Study.